New Alliance Capital
Shanghai-based VC/PE firm founded in 2008 managing RMB 17B AUM across funds focused on IT, healthcare, new energy, and high-tech manufacturing.
Shanghai, China · 8+ investments · 7 portfolio companies
- Headquarters
- Shanghai, China
- Founded
- 2008
- Website
- nac-capital.com
- Portfolio Companies
- 7
- Total Investments
- 8
- Last Investment
- Apr 2024
- Geographic Focus
- China
Investment Thesis
New Alliance Capital is a Venture Capital firm based in Shanghai, China. It has made 8 investments, including Lynk Pharmaceuticals, Arnatar Therapeutics and CF PharmTech. Focus areas include Healthcare and High-Tech Manufacturing.
Portfolio7
Co-investors24
Sign up to view co-investors
24 co-investors across 27 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×19 · Private Equity ×3 · Growth Equity ×1 · 19 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/new-alliance-capital"><img src="https://indexed.vc/api/badge/investor/new-alliance-capital" alt="New Alliance Capital on Indexed.vc" width="260" height="76" /></a>